PlainRecalls
FDA Drug Low Class III Terminated

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Reported: December 26, 2012 Initiated: September 27, 2012 #D-097-2013

Product Description

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Reason for Recall

Short Fill: some bottles contained less than 120-count per labeled claim.

Details

Recalling Firm
Genentech, Inc.
Units Affected
1128 bottles
Distribution
Nationwide
Location
South San Francisco, CA

Frequently Asked Questions

What product was recalled?
CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.. Recalled by Genentech, Inc.. Units affected: 1128 bottles.
Why was this product recalled?
Short Fill: some bottles contained less than 120-count per labeled claim.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 26, 2012. Severity: Low. Recall number: D-097-2013.